Browsing by Author David Cooper

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
5-Aug-2006CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialJintanat Ananworanich; Angèle Gayet-Ageron; Michelle Le Braz; Wisit Prasithsirikul; Ploenchan Chetchotisakd; Sasisopin Kiertiburanakul; Warangkana Munsakul; Phitsanu Raksakulkarn; Somboon Tansuphasawasdikul; Sunee Sirivichayakul; Matthias Cavassini; Urs Karrer; Daniel Genné; Reto Nüesch; Pietro Vernazza; Enos Bernasconi; Dominic Leduc; Claudette Satchell; Sabine Yerly; Luc Perrin; Andrew Hill; Thomas Perneger; Praphan Phanuphak; Hansjakob Furrer; David Cooper; Kiat Ruxrungtham; Bernard Hirschel; The HIV Netherlands Australia Thailand Research Collaboration; Hopitaux universitaires de Geneve; Bamrasnaradura Infectious Disease Institute; Khon Kaen University; Mahidol University; Vajira Hospital; Sanpatong Hospital; Buddhachinnaraj Hospital; UniversitatsSpital Bern; University of Liverpool; Kirby Institute; Chulalongkorn University; Centre Hospitalier Universitaire Vaudois; UniversitatsSpital Zurich; La Chaux-de-Fonds Hospital; Universitatsspital Basel; Kantonsspital St Gallen; Ospedale Civico, Lugano; Hôpital d'Annemasse
1-Feb-2007Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USAJim Ackland; Susan Allen; Daniel Barth-Jones; Deborah Birx; Elwyn Chomba; Gavin Churchyard; Ann Duerr; Shuigao Jin; Margaret Johnston; Patricia E. Fast; Alan Fix; Mary Foulkes; Dean Follmann; Raymond Hutubessy; Siobhan Malone; Ronald Gray; Abhay Indrayan; Jonathan Levin; Bonnie J. Mathieson; Timothy D. Mastro; John McNeil; Saladin Osmanov; Punnee Pitisuttithum; Barry Peters; Etienne Karita; Michael N. Robertson; R. Ramakrishnan; Helen Rees; Wasima Rida; Yuhua Ruan; Eric Sandström; Claudia Schmidt; Peter Smith; Steven Self; Georges Thiry; Judith Wasserheit; Frances Priddy; Ibou Thior; Mitchell Warren; David Cooper; Pontiano Kaleebu; Ruth Macklin; Godfrey Tangwa; Global BioSolutions; Rollins School of Public Health; Wayne State University School of Medicine; Centers for Disease Control and Prevention; Zambia-UAB HIV Research Project; Ernest Oppenheimer Hospital; Scientific Support Unit; Chinese Center for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; International AIDS Vaccine Initiative; Food and Drug Administration; Organisation Mondiale de la Sante; Bill and Melinda Gates Foundation; Johns Hopkins Bloomberg School of Public Health; University College of Medical Sciences; South African Medical Research Council; OAR HIV/AIDS Vaccine Coordinating Committee; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Mahidol University; Guy's and St Thomas' NHS Foundation Trust; Projet San Francisco Rwanda; Merck & Co., Inc.; National Institute of Epidemiology; University of Witwatersrand; Statistics Collaborative; Karolinska University Hospital; London School of Hygiene & Tropical Medicine; Statistical Center for HIV/AIDS Research and Prevention; IAVI; HIV Vaccine Trials Network; Emory University; Botswana Harvard AIDS Institute Partnership; AIDS Vaccine Advocacy Coalition; Kirby Institute; Uganda Virus Research Institute; Albert Einstein College of Medicine of Yeshiva University; Universite de Yaounde I
17-Oct-2003Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trialJintanat Ananworanich; Reto Nuesch; Michelle Le Braz; Ploechan Chetchotisakd; Asda Vibhagool; Saijai Wicharuk; Kiat Ruxrungtham; Hansjakob Furrer; David Cooper; Bernard Hirschel; Universitatsspital Basel; Hopitaux universitaires de Geneve; Khon Kaen University; Mahidol University; Chulalongkorn University; UniversitatsSpital Bern; Kirby Institute; Service des Maladies Infectieuses
5-Sep-2003Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitorsSunee Sirivichayakul; Kiat Ruxrungtham; Chaiwat Ungsedhapand; Wichai Techasathit; Sasiwimol Ubolyam; Theshinee Chuenyam; Sean Emery; David Cooper; Joep Lange; Praphan Phanuphak; Chulalongkorn University; The HIV Netherlands Australia Thailand Research Collaboration; Mahidol University; Kirby Institute; Natl. AIDS Therapy Evaluation Centre